Shampoo & Conditioner: Market Positioning Guide

Overview #

Most shampoo and conditioner briefs we receive start the same way: “We want something clean, effective, and premium.” That tells us almost nothing. The real positioning question is whether your brand is competing on scalp biology, hair fiber mechanics, sensory experience, or ingredient storytelling — because the formulation strategy, the claims language, and the packaging format all diverge from that single decision. Hair care is one of the most crowded shelves in beauty, and the brands that break through are the ones who pick a lane and formulate specifically for it, not the ones who try to be everything. We’ve helped launch over 200 hair care SKUs across mass, masstige, and prestige channels, and the positioning mistakes we see are remarkably consistent.

The Claims Landscape: What’s Defensible and What Gets You in Trouble #

Hair care claims sit in an interesting regulatory space. In the EU under EU Cosmetics Regulation 1223/2009, cosmetic claims must be substantiated, non-misleading, and not attribute medicinal properties to the product. In the US, the FDA Cosmetics Guidelines draw a hard line between cosmetic and drug claims — the moment you say your shampoo “treats” dandruff or “stimulates hair follicles,” you’ve crossed into OTC drug territory, which triggers a completely different compliance pathway. Most indie brands don’t realize this until we flag it during brief review.

Here’s how we categorize claims in our formulation briefs:

The claims we push back on most often are the bond-repair claims. Every brand wants to say “repairs bonds” because Olaplex made that language famous. But unless you’re using a bis-aminopropyl diglycol dimaleate system or a credible maleic acid derivative at the right concentration — typically 0.5–1.5% in a leave-on format — that claim has no mechanical basis. We’ve had three brand partners in the last 18 months who came to us after their first manufacturer let them run with that language. It’s not a good situation.

Scalp microbiome claims are the new frontier, and honestly, the evidence base is still catching up to the marketing. We’re cautious here. We can formulate with prebiotics, postbiotics, and select actives that have published microbiome data, but “balances your scalp microbiome” as a front-of-pack claim needs more than an ingredient supplier’s in-vitro study. We tell brand partners: if you want to go there, budget for a consumer use study with at least 30 subjects over 4 weeks minimum.

Differentiation Strategy: Picking Your Positioning Lane #

The four lanes we see working right now in the market are scalp-first, fiber science, sensory luxury, and ingredient transparency. Each one has a different formulation center of gravity.

Scalp-first positioning is where the most interesting technical work is happening. Brands in this lane are essentially arguing that healthy hair starts at the scalp — which is biologically correct — and building their entire system around scalp pH management (ideally 4.5–5.5), sebum regulation, and microbiome support. The formulation challenge is that effective scalp actives like salicylic acid, zinc pyrithione, or piroctone olamine all have regulatory constraints. Zinc pyrithione, for example, was restricted under EU Regulation 2021/1902 — it can no longer be used as a preservative in rinse-off hair products in the EU. That caught a lot of brands off guard. If you’re building a scalp line for EU distribution, you need to know this before you finalize your brief.

Fiber science positioning lives or dies on test data. This is where we see the most investment in third-party testing — combing force reduction, tensile strength, wet/dry friction coefficients. One clinical study we reference frequently for conditioning efficacy used a randomized, single-blind design with n=42 subjects over 8 weeks, measuring combing force reduction via Dia-Stron MTT175 tensile tester. The conditioner system containing 3% behentrimonium chloride (BTMAC) plus 2% cetyl alcohol plus a 1% hydrolyzed keratin blend showed a 61% reduction in wet combing force versus the placebo control. That’s the kind of number that holds up in marketing and in a regulatory challenge. Sensory data alone doesn’t.

Sensory luxury is the lane most brands think they want until they see the cost. Premium fragrance systems, exotic botanical extracts, silk proteins, caviar extracts — these add real COGS. A high-end fragrance blend at 1.2–1.5% loading in a shampoo adds roughly $0.15–$0.35 per unit at MOQ 5,000 units. That sounds small until you’re building a 6-SKU line. And fragrance is also your biggest stability and allergen risk — the SCCS Scientific Opinion on fragrance allergens has been reshaping EU-compliant formulations for years, with 26 allergens now requiring declaration at ≥0.001% in leave-on and ≥0.01% in rinse-off products.

Ingredient transparency is the clean beauty lane, and it’s more formulation-constrained than most brands expect. Sulfate-free systems require a complete rethink of the surfactant blend — you can’t just swap SLS for a gentler alternative and expect the same foam profile and viscosity behavior. We typically build these around sodium cocoyl isethionate, sodium lauroyl methyl isethionate, or cocamidopropyl betaine blends, and the rheology work alone adds 2–3 weeks to development time.

Where Most Brands Get the Formulation Wrong #

The single most common mistake: treating shampoo and conditioner as separate products instead of a system. We see this constantly. A brand will brief us on a shampoo with a very aggressive clarifying surfactant blend, then brief a conditioner that’s trying to compensate for the damage. That’s not a system — that’s two products fighting each other. When we take on a hair care line, we always ask to see both briefs together. The shampoo’s residue profile directly affects how the conditioner deposits and performs.

The second mistake is underestimating the scale-up behavior of conditioning systems. Cationic conditioning emulsions — the kind built on BTMAC or cetrimonium chloride with fatty alcohols — are notoriously sensitive to mixing temperature and shear rate. In our lab at 2kg scale, we can hit a beautiful, stable emulsion at 75°C with moderate overhead stirring. At 500kg production scale, the heat transfer dynamics change completely, and if the batch cools unevenly during the emulsification phase, you get a grainy, unstable product. We’ve seen this happen. One pilot batch failed because the production vessel had a dead zone near the bottom outlet valve where the temperature dropped 8°C below the rest of the batch. The emulsion looked fine at fill, failed at week 4 of stability testing. We now require temperature mapping of any new production vessel before we run a conditioning formula.

Preservative systems in hair care also get underestimated. Shampoos with high water activity and pH in the 5.0–6.5 range are a good growth environment for gram-negative bacteria. We run challenge testing per ISO Standards ISO 11930 on every new formula, and we’ve seen formulas that passed at lab scale fail challenge testing at production scale because the manufacturing environment introduced contamination that the preservative system couldn’t handle at the specified use level. The fix is usually straightforward — increase the preservative concentration or add a chelating agent like EDTA at 0.05–0.1% — but it adds time and cost that brands don’t budget for.

OEM Capability: What the Comparison Actually Looks Like #

This is a question we get directly from brand partners evaluating multiple manufacturers. The honest answer is that the capability gap between well-equipped OEM facilities and Western contract manufacturers has narrowed significantly over the last decade, but the differences that remain are real and worth understanding.

For hair care formulation and manufacturing, the relevant capabilities are: surfactant blending and rheology control, cationic emulsion manufacturing, active ingredient handling (heat-sensitive, pH-sensitive), and packaging compatibility testing. Most serious OEM facilities in this market have all of these. Where the differences show up is in regulatory documentation support for target markets, speed of stability data generation, and the depth of the formulation team’s active ingredient knowledge.

Western contract manufacturers typically have stronger in-house regulatory affairs teams for EU and US markets, and their stability protocols are often already aligned with ICH Stability Guidelines Q1A(R2) by default. That matters if you’re launching in regulated markets and need a complete technical dossier. On the other hand, lead times at Western CMOs for a new development project are typically 16–24 weeks from brief to pilot, versus 8–14 weeks in our experience here. And the cost differential on manufacturing is real — not because of quality shortcuts, but because of labor cost structures and raw material sourcing proximity.

For brands targeting NMPA registration for China market entry alongside their home market launch, working with a China-based OEM is almost always the more practical path. The documentation requirements, the ingredient compliance review, and the testing protocols are all things we handle internally. A Western CMO would need to subcontract most of that work.

The area where we’re honest about limitations: if a brand needs a very specific patented active system — something like a proprietary bond-building chemistry that’s licensed exclusively to a Western supplier — we may not be able to source an equivalent. We don’t pretend otherwise. For advanced actives and encapsulation technology, the supplier ecosystem matters as much as the manufacturer’s capability.

Formulation Notes for Brand Partners #

What market? What are you expecting on-pack? Those are the first two questions we ask every brand that comes to us with a hair care brief, because the answers determine almost everything downstream.

If you’re launching in the EU, we need to know your fragrance allergen strategy and whether you’re targeting any claims that touch on scalp biology — both of those have regulatory implications that affect the formula before we write a single line of the batch record. If you’re targeting the US mass market, the price-per-unit constraint usually means we’re working within a tighter raw material budget, which affects which conditioning actives and which surfactant systems are viable. If you’re building a prestige line for specialty retail, the sensory brief matters as much as the performance brief, and we’ll want to run a panel of 8–10 fragrance and texture prototypes before we lock a direction.

For most new brand partners, we recommend starting with a 2-SKU system — shampoo and conditioner — before expanding to treatments, masks, or scalp serums. Get the base system right first. The most common project delay we see is a brand trying to launch 6 SKUs simultaneously and running into stability or claims issues on two of them that hold up the whole line. Minimum order quantities for a 2-SKU hair care launch typically start at 1,000 units per SKU for our standard filling lines, with custom packaging requiring higher MOQs depending on the component supplier.

One more thing: if your positioning relies on a specific active ingredient at a specific concentration, tell us upfront. Don’t brief us on a “keratin treatment shampoo” and then reveal in week 3 that you need 5% hydrolyzed keratin — that changes the formula, the cost, and potentially the stability profile entirely.

Frequently Asked Questions #

Q: We want to say “sulfate-free” on pack — does that mean we can’t use any sulfates at all, or just SLS/SLES?

Technically “sulfate-free” in common market usage means free of sodium lauryl sulfate and sodium laureth sulfate specifically. But be careful — some retailers and certification bodies interpret it more broadly to include all sulfate-based surfactants. We always ask which retail channel you’re targeting before we finalize the surfactant system, because the definition varies. If you’re going into Sephora or Ulta, check their clean standards document first.

Q: Can we claim “repairs damaged hair” without a drug claim issue?

Yes, but the language has to stay in cosmetic territory. “Visibly reduces breakage,” “strengthens hair fiber,” or “improves hair resilience” are all defensible cosmetic claims if you have tensile testing data to back them up. “Repairs hair bonds” is borderline — it implies a structural change that some regulators read as a drug-like mechanism. We typically recommend “helps reinforce hair’s natural bonds” as a safer alternative. The difference sounds subtle but it matters in a regulatory review.

Q: How long does stability testing take before we can launch?

For a standard rinse-off hair care product, we run accelerated stability at 40°C/75% RH for 12 weeks alongside real-time testing at 25°C. That 12-week accelerated window is the minimum we’d recommend before launch — it gives you a reasonable prediction of 24-month shelf life. Some brands try to launch at 8 weeks of accelerated data. We advise against it. We’ve seen products that looked stable at 8 weeks show viscosity drift or color change by week 12.

Q: What’s the realistic MOQ for a custom-formula shampoo with a unique fragrance?

For a fully custom formula with a bespoke fragrance, you’re typically looking at a minimum of 2,000–3,000 units per SKU to make the fragrance development cost viable. The fragrance house usually requires a minimum purchase of 5–10 kg of the finished fragrance compound, and at 1–1.5% loading in a 250ml shampoo, that volume goes quickly. If you’re working with a smaller budget, we can work with our existing fragrance library and modify from there — that brings MOQ down to around 1,000 units.

Q: We’ve seen “microbiome-friendly” on a lot of competitor packs — is that a claim we can make?

You can, but it needs substantiation. The most defensible version of this claim is “microbiome-friendly tested” — meaning you’ve run a validated in-vitro or in-vivo test showing the formula doesn’t disrupt a representative scalp microbiome panel. Some ingredient suppliers provide this data for their specific actives, which can support the claim at the formula level. What you can’t do is just remove certain ingredients and call it microbiome-friendly without any test data. Regulators in the EU are paying increasing attention to microbiome claims, and we expect guidance to tighten over the next 2–3 years.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.